C

Catalyst Pharmaceuticals
D

CPRX

21.620
USD
-0.44
(-1.99%)
مغلق
حجم التداول
26,318
الربح لكل سهم
2
العائد الربحي
-
P/E
18
حجم السوق
2,578,691,686
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ANIP
    -1.750
    (-2.93%)
    57.990 USD
    A
    ARWR
    -1.040
    (-4.97%)
    19.900 USD
    I
    INO
    0.02000
    (0.91%)
    2.23000 USD
    K
    KPTI
    -0.00940
    (-1.55%)
    0.59840 USD
    R
    RARE
    -1.920
    (-4.31%)
    42.590 USD
    المزيد
الأخبار
المقالات

العنوان: Catalyst Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.